BCTX
BriaCell Therapeutics Corp.
+0.32 (+8.93%)3.88USD115K成交股數33.7M市值1.7本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 7 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 6.0M | 6.1M | 6.7M | 7.1M | 4.8M | 5.7M | 3.7M | 7.7M | 8.3M | 6.9M | 5.2M | 3.9M |
| 銷售管理費用 | 1.7M | 1.5M | 1.6M | 1.4M | 1.5M | 1.5M | 1.5M | 1.6M | 1.6M | 1.6M | 2.5M | 1.8M |
| 營業利益 | −7.6M+20% | −7.5M+5% | −8.3M+62% | −8.6M-7% | −6.3M-36% | −7.2M-16% | −5.2M-33% | −9.2M+63% | −9.8M | −8.5M | −7.7M | −5.7M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −7.2M+17% | −7.2M+15% | −8.2M+41% | −8.1M-572% | −6.1M-46% | −6.3M-205% | −5.8M+140% | 1.7M-135% | −11.3M | 6.0M | −2.4M | −4.9M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.99-94% | -2.58-89% | -4.35-87% | 10.21+534% | -16.42+54% | -23.31+4562% | -32.67+23236% | 1.61-603% | -10.64 | -0.50 | -0.14 | -0.32 |
| 稀釋股數 | 7.3M | 2.8M | 1.9M | 423K | 373K | 270K | 178K | 1.1M | 1.1M | 16.7M | 15.6M | 15.5M |
資產負債表 期末餘額
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 6.9M | 29.9M | 2.7M | 10.5M | 12.5M | 5.0M | 5.8M | 936K | 6.2M | 13.6M | 21.3M | 28.2M |
| 應收帳款 | – | – | – | – | – | – | – | 15K | 30K | 21K | 19K | 15K |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 27.1M | 33.6M | 13.1M | 21.6M | 17.0M | 9.4M | 10.4M | 6.2M | 12.2M | 18.6M | 27.2M | 29.7M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | 23.4M | 30.2M | 9.4M | 17.3M | 11.9M | 3.2M | 3.7M | −6.2M | −8.3M | 2.5M | −3.8M | −5.9M |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | −7.7M+11% | – | – | – | −7.0M | – | – | −7.6M | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | 4K | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −26.3M | –% | -62.19 | – |
| FY2024 | – | – | −4.8M | –% | -43.68 | −24.6M |
| FY2023 | – | – | −20.3M | –% | -1.30 | – |
| FY2022 | – | – | −26.8M | –% | -1.73 | – |
| FY2022 | – | – | – | –% | – | – |
| FY2021 | – | – | −13.8M | –% | – | – |
| FY2021 | – | – | – | –% | – | – |